Avondale Partners Downgrades TrueBlue (TBI) to Underperform

Go back to Avondale Partners Downgrades TrueBlue (TBI) to Underperform

TrueBlue (TBI) Misses Q3 EPS by 5c, Q4 Guidance Falls Short

October 19, 2016 4:16 PM EDT

TrueBlue (NYSE: TBI) reported Q3 EPS of $0.70, $0.05 worse than the analyst estimate of $0.75. Revenue for the quarter came in at $697.1 million versus the consensus estimate of $715.69 million.

GUIDANCE:

TrueBlue sees Q4 2016 EPS of $0.54-$0.59, versus the consensus of $0.69. TrueBlue sees Q4... More